Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-03-30

Clinical Trial Update: Beta-glucan and Insulin Sensitivity in Obese Humans [NA]

View source ↗

Summary

A completed clinical trial evaluated whether beta-glucan improves insulin sensitivity in obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Beta Glucan (beta-glucan)

Snippet

Sponsor: Marek Straczkowski | Conditions: Obesity | NA | Status: COMPLETED